Goldman Sachs Group Inc Argenx Se Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Argenx Se stock. As of the latest transaction made, Goldman Sachs Group Inc holds 132,182 shares of ARGX stock, worth $74.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
132,182
Previous 123,041 7.43%
Holding current value
$74.6 Million
Previous $52.9 Million 35.48%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$434.22 - $551.9 $3.97 Million - $5.04 Million
9,141 Added 7.43%
132,182 $71.7 Million
Q2 2024

Aug 13, 2024
BUY
$356.01 - $451.55 $567,123 - $719,319
1,593 Added 1.31%
123,041 $52.9 Million
Q1 2024

May 15, 2024
SELL
$356.95 - $413.29 $46.7 Million - $54.1 Million
-130,921 Reduced 51.88%
121,448 $47.8 Million
Q4 2023

Feb 13, 2024
BUY
$338.91 - $506.01 $33.5 Million - $50 Million
98,736 Added 64.27%
252,369 $96 Million
Q3 2023

May 14, 2024
SELL
$369.35 - $548.43 $36.5 Million - $54.1 Million
-98,736 Reduced 39.12%
153,633 $75.5 Million
Q3 2023

Nov 14, 2023
BUY
$369.35 - $548.43 $5.89 Million - $8.74 Million
15,940 Added 11.58%
153,633 $75.5 Million
Q2 2023

May 14, 2024
SELL
$360.14 - $422.58 $11.2 Million - $13.2 Million
-31,213 Reduced 18.48%
137,693 $53.7 Million
Q2 2023

Aug 14, 2023
SELL
$360.14 - $422.58 $11.2 Million - $13.2 Million
-31,213 Reduced 18.48%
137,693 $53.7 Million
Q1 2023

May 14, 2024
SELL
$334.23 - $403.65 $7.01 Million - $8.47 Million
-20,974 Reduced 11.05%
168,906 $62.9 Million
Q1 2023

May 11, 2023
SELL
$334.23 - $403.65 $7.01 Million - $8.47 Million
-20,974 Reduced 11.05%
168,906 $62.9 Million
Q4 2022

May 14, 2024
SELL
$342.17 - $402.31 $19 Million - $22.3 Million
-55,501 Reduced 22.62%
189,880 $71.9 Million
Q4 2022

Feb 13, 2023
SELL
$342.17 - $402.31 $19 Million - $22.3 Million
-55,501 Reduced 22.62%
189,880 $71.9 Million
Q3 2022

May 14, 2024
SELL
$343.2 - $395.75 $9.44 Million - $10.9 Million
-27,510 Reduced 10.08%
245,381 $86.6 Million
Q3 2022

Nov 10, 2022
SELL
$343.2 - $395.75 $9.44 Million - $10.9 Million
-27,510 Reduced 10.08%
245,381 $86.6 Million
Q2 2022

May 14, 2024
BUY
$269.58 - $378.88 $5.53 Million - $7.78 Million
20,522 Added 8.13%
272,891 $103 Million
Q2 2022

Aug 15, 2022
SELL
$269.58 - $378.88 $16.5 Million - $23.2 Million
-61,278 Reduced 18.34%
272,891 $103 Million
Q1 2022

May 16, 2022
BUY
$254.45 - $351.06 $32.8 Million - $45.2 Million
128,759 Added 62.68%
334,169 $105 Million
Q4 2021

Feb 14, 2022
BUY
$272.01 - $353.03 $15.9 Million - $20.6 Million
58,338 Added 39.67%
205,410 $71.9 Million
Q3 2021

Nov 10, 2021
BUY
$295.0 - $350.58 $43.4 Million - $51.6 Million
147,072 New
147,072 $44.4 Million

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email